An in-depth look to DAIHAN PHARMACEUTICAL operating, investing, and financing activities

023910 free cash flow for Q3 24 is 8.25 B KRW. For 2023, 023910 free cash flow was 17.58 B KRW and operating cash flow was 38.86 B KRW.